We are live on ! Find out more
PCM

Puissance Capital Management Portfolio holdings

AUM $17.3M
1-Year Est. Return 149.36%
This Fund
S&P 500
This Quarter Est. Return
-43.63%
1 Year Est. Return
+149.36%
3 Year Est. Return
+115.5%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$44.8M
AUM Growth
-$57.4M
Cap. Flow
-$1.04M
Cap. Flow %
-2.31%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CRVS icon
Corvus Pharmaceuticals
CRVS
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 24.28%
2 Healthcare 22.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRAY
1
DELISTED
ViewRay, Inc.
VRAY
$19.8M 44.27%
6,842,975
– –
CHRN
2
ChronoScale Holdings
CHRN
$2.69B
$10.9M 24.28%
91,266
– –
KDMN
3
DELISTED
Kadmon Holdings, Inc.
KDMN
$7.53M 16.79%
3,020,596
– –
BLPH
4
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$4M 8.92%
553,250
– –
TCON
5
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$2.06M 4.59%
23,009
– –
SCYX icon
6
SCYNEXIS
SCYX
$37.4M
$403K 0.9%
4,735
– –
CRVS icon
7
Corvus Pharmaceuticals
CRVS
$1.1B
$114K 0.25%
38,010
-246,859
-87% -$1.04M

Similar funds

FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
IAM
ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return
FP
FFL Partners San Francisco, California $16.1M AUM 46.91% 1-Year Est. Return
AF
AMG Funds Stamford, Connecticut $20M AUM 3.75% 1-Year Est. Return
TCS
Texas Children's Houston, Texas $20.5M AUM 51.2% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
PCM
Proxima Capital Management New York $21M AUM 3.49% 1-Year Est. Return
NC
Numen Capital London, United Kingdom $13.5M AUM 47.6% 1-Year Est. Return

Puissance Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Puissance Capital Management held 7 positions worth $44.8M, down 56% from $102M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 0%. Puissance Capital Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare.

  • Puissance Capital Management's biggest Q3 2019 reduction was Corvus Pharmaceuticals, cutting an estimated $1.04M.
  • Puissance Capital Management's ten largest holdings make up 100% of its $44.8M portfolio in Q3 2019.
  • Puissance Capital Management opened 0 new positions and closed 0 in Q3 2019.
  • Puissance Capital Management's portfolio value fell 56% quarter-over-quarter to $44.8M.

Based on Puissance Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.